Hexagon Nutrition IPO is coming out in 2026. People want to know if they should invest in it or not. The Indian market for companies is very active right now. Hexagon Nutrition works in the field of nutrition and healthcare. This field is growing because people are becoming more health conscious. They want to eat food and take care of themselves.

To make a decision we need to look at the companys basics how it can grow, the risks and its value. Lets break down all the things about Hexagon Nutrition IPO.

Here are the details of the Hexagon Nutrition IPO:

- It opens on June 5 2026 and closes on June 9 2026.

- The expected listing date is June 12 2026.

- The price range is ₹42 to ₹45 per share.

- The total issue size is ₹138.87 Crore.

- It is a book-built issue.

- The shares will be listed on NSE and BSE.

- You need to buy a minimum of 333 shares, which costs ₹14,985.

- The allotment date is June 10 2026.

This IPO is mostly for existing shareholders to sell their shares.

The current grey market premium for Hexagon Nutrition IPO is not very high.

- The current GMP is ₹0 to ₹1.

- The expected listing price is around ₹45 to ₹46.

- The estimated listing gain is 0% to 2%.

We should remember that GMP is not a number and can change before the listing. Some IPOs have listed below the expected GMP while others have done better than expected.

Hexagon Nutrition is a company that does research in nutrition. They make products for healthcare and nutrition.

- They have products for nutrition.

- They make premixes.

- They have nutrition products.

- They provide food fortification solutions.

- They also have wellness products.

Their products are used by hospitals, healthcare institutions, food manufacturers and consumers. The company works in an industry that has the potential to grow in the term.

If we look at the companys performance we can see that it has improved over the years.

- In FY23 the revenue was ₹278.5 Crore.

- In FY24 the revenue was ₹297.7 Crore.

- In FY25 the revenue was ₹324.9 Crore.

- The net profit in FY23 was ₹5.8 Crore.

- The net profit in FY24 was ₹12.2 Crore.

- The net profit in FY25 was ₹24.4 Crore.

The profit has grown faster than the revenue, which means the company is becoming more efficient. The company has almost doubled its profit in the year which is a good sign.

The strengths of Hexagon Nutrition are:

1. The healthcare industry is growing.

2. The company has a range of products.

3. They focus on research.

4. Their profitability is improving.

There are also some risks that investors should know about:

1. Most of the IPO is for existing shareholders to sell their shares.

2. The nutrition and healthcare market is very competitive.

3. The current GMP is not showing demand.

The valuation of Hexagon Nutrition IPO seems reasonable. The company has shown revenue growth improving margins and rising profits. It is also in a growing industry. For long-term investors the quality of the business is more important than short-term gains.

The expected listing performance of Hexagon Nutrition IPO could be moderate. There are three scenarios:

- Bullish scenario: The listing price could be ₹50 to ₹55 with a gain of 10% to 22%.

- Base scenario: The listing price could be ₹45 to ₹48 with a gain of 0% to 7%.

- Bearish scenario: The listing price could be ₹40 to ₹44 with a loss of 2% to 11%.

In the term Hexagon Nutritions future depends on its ability to grow in the nutrition and wellness market. The healthcare and nutrition industry is expected to benefit from increasing health awareness rising income, government nutrition programs and growing demand for fortified foods.

Should you invest in Hexagon Nutrition IPO? For listing gains the opportunity seems average.. For long-term investors the company looks interesting because of its improving financials and exposure to a growing industry. The verdict is neutral, for listing gain investors. Consider applying for long-term investors. The risk level is moderate. The IPO may not be a blockbuster. It has reasonable long-term potential.

Hexagon Nutrition is entering the market at a time when nutrition and healthcare businesses are becoming more important in India. The company has shown improving performance and operates in a sector that could benefit from long-term growth. While the current GMP trends do not point to listing gains long-term investors might see value in the companys growth story if the management continues to execute well. As always investors should evaluate their risk appetite, investment horizon and portfolio allocation before applying to any IPO.